Novo Ramps Up In China, Roche Downplays Branded Generics, GSK Talks Up Japan While Hitting "The Inflection Point": Emerging Markets Round Up (Part 2)

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.